Загрузка...
p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD
COPD represents a major respiratory disorder, causing significant morbidity and mortality throughout the world. While therapies exist for COPD, they are not always effective, and many patients experience exacerbations and morbidity despite current therapies. Study of the molecular mechanisms involve...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4030417/ https://ncbi.nlm.nih.gov/pubmed/22365729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2012.01.016 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|